<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVE: Progression of a colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> to <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> occurs in a minority of <z:mpath ids='MPATH_270'>adenomas</z:mpath> and is the most crucial step in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> pathogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>In the majority of cases, this is associated with gain of a substantial part of chromosome 20q, indicating that multiple genes on the 20q amplicon may drive <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to identify genes located on the 20q amplicon that promote progression of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Functional assays were performed for 32 candidate driver genes for which a positive correlation between 20q DNA copy number and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression had been demonstrated </plain></SENT>
<SENT sid="4" pm="."><plain>Effects of gene knockdown on cell viability, anchorage-independent growth, and invasion were analysed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines with 20q gain </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">Colorectal tumour</z:e> protein expression was examined by immunohistochemical staining of tissue microarrays </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: TPX2, AURKA, CSE1L, DIDO1, HM13, TCFL5, SLC17A9, RBM39 and PRPF6 affected cell viability and/or anchorage-independent growth </plain></SENT>
<SENT sid="7" pm="."><plain>Chromosome 20q DNA copy number status correlated significantly with TPX2 and AURKA protein levels in a series of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, downmodulation of TPX2 and AURKA was shown to inhibit invasion </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: These data identify TPX2 (20q11) and AURKA (20q13.2) as two genes located on distinct regions of chromosome 20q that promote 20q amplicon-driven progression of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore the selection advantage imposed by 20q gain in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> is achieved by gain-of-function of <z:e sem="disease" ids="C0346429" disease_type="Neoplastic Process" abbrv="">multiple cancer</z:e>-related genes-knowledge that can be translated into novel tests for early diagnosis of progressive <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
</text></document>